KALV - Kalvista Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - KALV (1348911)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
28 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2019-09-26
KALVSoland Daniel BDirP - Purchase$11.88+10,00010,000New+$118,750
M
2019-07-26
KALVCha AlbertDirP - Purchase$16.99+56,3671,147,059+5%+$957,737
D
2019-07-22
KALVYea ChristopherChief Development OfficerS - Sale+OE$18.35-7,35582,969-8%-$134,930
M
2019-07-22
KALVFeener Edward P.Chief Scientific OfficerS - Sale$18.62-3,30096,734-3%-$61,443
M
2019-07-17
KALVCha AlbertDirP - Purchase$17.79+61,2801,420,429+5%+$1,090,296
2019-07-15
KALVCrockett Thomas AndrewCEOS - Sale$17.04-10,000248,510-4%-$170,407
D
2019-04-22
KALVYea ChristopherChief Development OfficerS - Sale+OE$26.04-7,35582,969-8%-$191,530
2019-04-15
KALVCrockett Thomas AndrewCEOS - Sale$24.80-10,000258,510-4%-$247,958
DM
2019-04-18
KALVPalleiko Benjamin LCBO, CFO, SecretaryS - Sale+OE$25.70-3,07332,500-9%-$78,976
2019-04-17
KALVFeener Edward P.Chief Scientific OfficerS - Sale$24.92-4,000100,034-4%-$99,666
M
2019-04-08
KALVSvlsf Iv, LLC10%S - Sale$29.20-50,00047,471-51%-$1,460,145
D
2019-04-05
KALVMaetzel AndreasSVP MedicalS - Sale+OE$30.00-5,0000-100%-$150,011
M
2019-03-29
KALVSvlsf Iv, LLC10%S - Sale$28.03-97,07448,851-67%-$2,720,897
M
2019-03-26
KALVSvlsf Iv, LLC10%S - Sale$28.84-124,67551,531-71%-$3,596,032
2019-03-18
KALVSvlsf Iv, LLC10%S - Sale$26.70-262,47054,973-83%-$7,007,949
2019-03-18
KALVVenrock Healthcare Capital Partners Ii, L.P.10%S - Sale$28.75-500,0001,544,112-24%-$14,375,000
2019-03-14
KALVCrockett Thomas AndrewCEOS - Sale$30.16-3,000268,510-1%-$90,484
M
2019-03-04
KALVSvlsf Iv, LLC10%S - Sale$22.96-75,71062,219-55%-$1,738,476
M
2019-02-19
KALVSvlsf Iv, LLC10%S - Sale$20.55-214,19864,309-77%-$4,401,353
D
2019-01-25
KALVYea ChristopherChief Development OfficerS - Sale+OE$17.06-5,45382,969-6%-$93,015
DM
2019-01-22
KALVYea ChristopherChief Development OfficerS - Sale+OE$17.01-1,90282,969-2%-$32,344
2019-01-16
KALVFeener Edward P.Chief Scientific OfficerS - Sale$19.55-4,000104,034-4%-$78,210
2019-01-14
KALVCrockett Thomas AndrewCEOS - Sale$19.33-10,000271,510-4%-$193,328
M
2019-01-03
KALVSvlsf Iv, LLC10%S - Sale$20.25-4,29970,222-6%-$87,073
M
2018-12-28
KALVSvlsf Iv, LLC10%S - Sale$20.01-29,35270,341-29%-$587,242
2018-12-19
KALVSvlsf Iv, LLC10%S - Sale$20.02-2,13671,152-3%-$42,758
2018-09-10
KALVOronsky Arnold LDirP - Purchase$17.00+58,824388,766+18%+$1,000,008
2018-09-10
KALVCha AlbertDirP - Purchase$17.00+1,058,8241,359,149+353%+$18,000,008
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top